Effectiveness and tolerability of topical clindamycin vs. benzoyl peroxide combination gel in managing mild-to-moderate acne
Dr. Harshvardhan Gowda
(MBBS, MD (DVL)
Consultant Dermatologists and Cosmetologist at Dr. Harsha’s Skin Care & Cosmetology Center
Karnataka
Acne vulgaris, commonly known as acne, is a chronic inflammatory skin condition that affects a significant portion of the population, particularly adolescents and young adults. Managing acne requires a multifaceted approach, with various topical and systemic therapies available. Topical clindamycin and benzoyl peroxide have emerged as leading treatments for mild to moderate acne. Given the high prevalence of acne and its impact on quality of life, understanding the relative efficacy and tolerability of clindamycin and benzoyl peroxide is crucial. A comprehensive review of the existing literature was conducted to evaluate and compare the effectiveness and tolerability of topical clindamycin alone vs. its combination with benzoyl peroxide in the treatment of mild to moderate acne.
A total of 200 patients with acne were randomized to receive clindamycin 1% gel (n=100) and clindamycin 1% gel plus benzoyl peroxide 2.5% cream (n=100). The combination therapy group showed a greater reduction in total lesion count (64.7% reduction) compared to the clindamycin group (48.6% reduction) with a significant difference (p<0.001). Investigator global assessment score improvement was also more substantial in the combination group (52.9% improvement) compared to the clindamycin group (44.4% improvement, p=0.046). Adverse events were more frequent in the combination group but did not significantly affect compliance.
The combination of clindamycin and benzoyl peroxide was shown to be more effective for mil-to-moderate acne than clindamycin alone, despite a higher but manageable rate of adverse events. This suggests that combination therapy offers a better balance of efficacy and tolerability.
Reference: Sen A, Ram AK. Comparative study on the effectiveness and tolerability of topical clindamycin versus benzoyl peroxide gel in mild to moderate acne management. Int J Med Pharm Res. 2024;5(1):42-47.
